From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift. Review uri icon

Overview

abstract

  • This review examines the paradigm shift around multidrug-resistant tuberculosis (MDR-TB). This shift has centered largely on the activities of institutions participating in the World Health Organization's Working Group on DOTS-Plus for MDR-TB. We review the important milestones since 1995, namely, the emergence of new evidence, the construction of new mechanisms, and the building of consensus to support new policy guidelines. This paper offers a case study of the construction of a model of good global governance that--if the opportunity is taken--can improve access to effective TB care through improving and helping to expand the WHO-recommended DOTS strategy.

publication date

  • January 1, 2003

Research

keywords

  • Antitubercular Agents
  • Directly Observed Therapy
  • Tuberculosis, Multidrug-Resistant
  • Tuberculosis, Pulmonary

Identity

Scopus Document Identifier

  • 0038520904

Digital Object Identifier (DOI)

  • 10.1016/s1472-9792(02)00078-1

PubMed ID

  • 12758190

Additional Document Info

volume

  • 83

issue

  • 1-3